Derycz Scientific's Leadership Aggressively Focused on Helping Pharma Companies Manage Content Efficiently and Cost-Effectively
(firmenpresse) - LOS ANGELES, CA -- (Marketwire) -- 10/20/11 -- Derycz Scientific, Inc. (OTCBB: DYSC) describes itself as "The Information Logistics Company." For pharmaceutical firms and other knowledge-based businesses that deal with large volumes of peer-reviewed published literature, the value proposition of Derycz soon becomes clear: The company facilitates and optimizes processes for procuring and using full-text research articles from the lab to the clinic; supports good copyright practices for circulating such material to a company's researchers; and provides dedicated customer service support to oversee these outsourced services -- and that's only part of their story.
In an exclusive Q&A report, Peter Derycz, Founder and CEO of Derycz Scientificreveals details about the firm's suite of products for content delivery and management and what his firm's value proposition means to the healthcare/biotech investment community. The exclusive report is now available at:
In addition, investors may access BioMedReports' for use as a tool in more profitable trading by visiting:
News developments and live healthcare sector updates are available constantly via Twitter at:
About BioMedReports.Com
BioMedReports is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies in the healthcare sector of the markets. Full disclosures and information about these stocks and news are available at BioMedReports.Com
Media Contacts Only:
Mary Davila
Assistant Editor
BioMedReports.Com
e-mail:
Tel: +1 323 472 4480
Fax: +1 888 210 3556
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 20.10.2011 - 06:07 Uhr
Sprache: Deutsch
News-ID 1048106
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
LOS ANGELES, CA
Phone:
Kategorie:
Commercial & Investment Banking
Anmerkungen:
Diese Pressemitteilung wurde bisher 110 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Derycz Scientific's Leadership Aggressively Focused on Helping Pharma Companies Manage Content Efficiently and Cost-Effectively
"
steht unter der journalistisch-redaktionellen Verantwortung von
BioMedReports (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
